Australia Cannabidiol Market Size & Outlook, 2023-2030
Related Markets
Australia cannabidiol market highlights
- The Australia cannabidiol market generated a revenue of USD 32.3 million in 2023 and is expected to reach USD 247.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 33.8% from 2024 to 2030.
- In terms of segment, hemp was the largest revenue generating product in 2023.
- Hemp is the most lucrative product segment registering the fastest growth during the forecast period.
Cannabidiol market data book summary
| Market revenue in 2023 | USD 32.3 million |
| Market revenue in 2030 | USD 247.6 million |
| Growth rate | 33.8% (CAGR from 2023 to 2030) |
| Largest segment | Hemp |
| Fastest growing segment | Hemp |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hemp, Marijuana |
| Key market players worldwide | Medical Marijuana Inc, Canopy Growth Corp, Elixinol Wellness Ltd Ordinary Shares, The Cronos Group, Isodiol International Inc, Endoca, Folium Biosciences, NuLeaf Naturals, PharmaHemp |
Other key industry trends
- In terms of revenue, Australia accounted for 0.4% of the global cannabidiol market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan cannabidiol market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 247.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cannabidiol Market Scope
Cannabidiol Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| PharmaHemp | View profile | 51-100 | Ljubljana, Ljubljana Urban Commune, Slovenia, Europe | https://b2b.pharma-hemp.com |
| NuLeaf Naturals | View profile | 51-100 | Denver, Colorado, United States, North America | https://nuleafnaturals.com/ |
| Folium Biosciences | View profile | 101-250 | Colorado Springs, Colorado, United States, North America | https://foliumbiosciences.com/ |
| Endoca | View profile | 1-10 | Hoofddorp, Noord-Holland, The Netherlands, Europe | https://www.endoca.com/pl |
| Isodiol International Inc | View profile | 197 | 200 Granville Street, Suite 2710, Vancouver, BC, Canada, V6C 1S4 | https://www.isodiol.com |
| Elixinol Wellness Ltd Ordinary Shares | View profile | - | 680 George Street, Level 12, Sydney, NSW, Australia, 2000 | https://www.elixinolwellness.com |
| Medical Marijuana Inc | View profile | 85 | 2384 La Mirada Drive, Vista, CA, United States, 92081 | https://www.medicalmarijuanainc.com |
| The Cronos Group | View profile | 1001-5000 | Kontich, Antwerpen, Belgium, Europe | https://cronos-groep.be/ |
| Canopy Growth Corp | View profile | 1621 | 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8 | https://www.canopygrowth.com |
Australia cannabidiol market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cannabidiol market will help companies and investors design strategic landscapes.
Hemp was the largest segment with a revenue share of 79.88% in 2023. Horizon Databook has segmented the Australia cannabidiol market based on hemp, marijuana covering the revenue growth of each sub-segment from 2018 to 2030.
Since the legalization of medical cannabis in Australia in 2016, the number of patients seeking a prescription for medical cannabis and its derived products has increased tremendously. The number of companies operating in the medical cannabis market is also rising, with new companies being listed on the Australian Stock Exchange (ASX).
In April 2023, Aurora Cannabis Inc. and MedReleaf Australia collaborated to introduce IndiMed Tempo 26, a line of new dried cannabis products with higher THC content for eligible patients under the MedReleaf Concession Scheme (MCS). The introduction of Tempo 26 to the product portfolio offers medical practitioners a broader range of prescription options for their cannabis patients.
However, the Australian CBD market is expected to witness slower growth as compared to North America, mainly due to stringent regulatory guidelines for prescribing medical cannabis (oils and tinctures) as a therapeutic product in Australia.
Reasons to subscribe to Australia cannabidiol market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia cannabidiol market databook
-
Our clientele includes a mix of cannabidiol market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia cannabidiol market , including forecasts for subscribers. This country databook contains high-level insights into Australia cannabidiol market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia cannabidiol market size, by product, 2018-2030 (US$M)
Australia Cannabidiol Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
